PAPER Gauthier S, Rockwood K
SEARCH RESULTS
331254 RESULTS
PAPER Petrovitch H, White L
Exercise and cognitive function.
Lancet Neurol. 2005 Nov;4(11):690-1. PubMed: 16239172PAPER Kemp S, Goulding P, Spencer J, Mitchell AJ
Unusually rapid and severe cognitive deterioration after mild traumatic brain injury.
Brain Inj. 2005 Dec 20;19(14):1269-76. PubMed: 16286343PAPER Frisoni GB, Filippi M
Multiple sclerosis and Alzheimer disease through the looking glass of MR imaging.
AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2488-91. PubMed: 16286389PAPER Kohler CG, Anselmo-Gallagher G, Bilker W, Karlawish J, Gur RE, Clark CM
Emotion-discrimination deficits in mild Alzheimer disease.
Am J Geriatr Psychiatry. 2005 Nov;13(11):926-33. PubMed: 16286435PAPER Harwood DG, Sultzer DL, Feil D, Monserratt L, Freedman E, Mandelkern MA
Frontal lobe hypometabolism and impaired insight in Alzheimer disease.
Am J Geriatr Psychiatry. 2005 Nov;13(11):934-41. PubMed: 16286436PAPER Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L, Alzheimer's Disease Cooperative Study, Valproate Nursing Home Study Group
Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.
Am J Geriatr Psychiatry. 2005 Nov;13(11):942-9. PubMed: 16286437PAPER Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, Kahn SE, Keeling ML, Craft S
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.
Am J Geriatr Psychiatry. 2005 Nov;13(11):950-8. PubMed: 16286438PAPER Barnes LL, Wilson RS, Li Y, Aggarwal NT, Gilley DW, McCann JJ, Evans DA
Racial differences in the progression of cognitive decline in Alzheimer disease.
Am J Geriatr Psychiatry. 2005 Nov;13(11):959-67. PubMed: 16286439PAPER Ryu SH, Katona C, Rive B, Livingston G
Persistence of and changes in neuropsychiatric symptoms in Alzheimer disease over 6 months: the LASER-AD study.
Am J Geriatr Psychiatry. 2005 Nov;13(11):976-83. PubMed: 16286441PAPER Wilson RS, Krueger KR, Kamenetsky JM, Tang Y, Gilley DW, Bennett DA, Evans DA
Hallucinations and mortality in Alzheimer disease.
Am J Geriatr Psychiatry. 2005 Nov;13(11):984-90. PubMed: 16286442PAPER Kircher TT, Erb M, Grodd W, Leube DT
Cortical activation during cholinesterase-inhibitor treatment in Alzheimer disease: preliminary findings from a pharmaco-fMRI study.
Am J Geriatr Psychiatry. 2005 Nov;13(11):1006-13. PubMed: 16286445PAPER Hirschman KB, Joyce CM, James BD, Xie SX, Casarett DJ, Karlawish JH
Would caregivers of Alzheimer disease patients involve their relative in a decision to use an AD-slowing medication?
Am J Geriatr Psychiatry. 2005 Nov;13(11):1014-21. PubMed: 16286446PAPER Csernansky JG, Wang L, Miller JP, Galvin JE, Morris JC
Neuroanatomical predictors of response to donepezil therapy in patients with dementia.
Arch Neurol. 2005 Nov;62(11):1718-22. PubMed: 16286546PAPER Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
Arch Neurol. 2005 Nov;62(11):1728-33. PubMed: 16286547Current Filters
No filters selected